Total Payments
$5,972
2024 Payments
$335.59
Companies
39
Transactions
400
Medicare Patients
1,988
Medicare Billing
$192,166
Payment Breakdown by Category
Food & Beverage$5,936 (99.4%)
Other$22.15 (0.4%)
Education$13.18 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,936 | 396 | 99.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.15 | 1 | 0.4% |
| Education | $13.18 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $1,714 | 177 | $0 (2024) |
| ABBVIE INC. | $817.77 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $418.90 | 24 | $0 (2024) |
| Celgene Corporation | $399.44 | 21 | $0 (2023) |
| UCB, Inc. | $244.65 | 13 | $0 (2024) |
| Eisai Inc. | $230.48 | 11 | $0 (2024) |
| Lilly USA, LLC | $191.55 | 10 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $182.08 | 10 | $0 (2024) |
| Genentech USA, Inc. | $178.64 | 10 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $157.13 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $335.59 | 15 | ABBVIE INC. ($70.24) |
| 2023 | $1,634 | 79 | Biogen, Inc. ($355.58) |
| 2022 | $1,192 | 68 | ABBVIE INC. ($287.08) |
| 2021 | $1,377 | 108 | Biogen, Inc. ($447.18) |
| 2020 | $691.54 | 64 | Biogen, Inc. ($275.23) |
| 2019 | $488.35 | 45 | Biogen, Inc. ($187.17) |
| 2018 | $50.49 | 4 | Biogen, Inc. ($28.19) |
| 2017 | $203.05 | 17 | Biogen, Inc. ($144.55) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: NEUROLOGY | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Neurology | ||||||
| 03/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Neurology | ||||||
| 03/11/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Neuroscience | ||||||
| 03/07/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Neurology | ||||||
| 03/06/2024 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $34.99 | General |
| Category: Narcoplepsy | ||||||
| 01/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: EPILEPSY | ||||||
| 01/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Neuropsychiatry | ||||||
| 01/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Neurology | ||||||
| 01/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Neurology | ||||||
| 01/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Rare Disease | ||||||
| 12/14/2023 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/12/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: Neuroscience | ||||||
| 12/08/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Neurology | ||||||
| 12/04/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $16.83 | General |
| Category: Neurology | ||||||
| 11/30/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: Neuroscience | ||||||
| 11/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: PAIN | ||||||
| 11/20/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 421 | 546 | $158,816 | $45,164 |
| 2022 | 7 | 428 | 532 | $146,016 | $42,321 |
| 2021 | 8 | 566 | 681 | $191,213 | $55,238 |
| 2020 | 8 | 573 | 675 | $177,104 | $49,443 |
Total Patients
1,988
Total Services
2,434
Medicare Billing
$192,166
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 228 | $60,522 | $19,696 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 130 | $28,600 | $7,103 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $16,660 | $5,875 | 35.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 45 | 78 | $25,415 | $5,681 | 22.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 22 | 23 | $11,201 | $2,886 | 25.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 14 | 14 | $10,010 | $2,224 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $6,408 | $1,698 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 173 | 241 | $64,106 | $20,438 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 139 | $30,580 | $7,605 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $17,340 | $5,453 | 31.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 35 | 59 | $17,641 | $4,487 | 25.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 13 | 13 | $6,331 | $1,791 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $4,272 | $1,287 | 30.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 12 | 13 | $5,746 | $1,261 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 204 | $54,013 | $18,249 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 157 | 182 | $39,788 | $10,372 | 26.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 78 | 78 | $26,520 | $9,119 | 34.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 55 | 107 | $31,993 | $7,680 | 24.0% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 28 | 29 | $14,123 | $3,946 | 27.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 19 | 19 | $13,585 | $2,496 | 18.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $8,277 | $1,823 | 22.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 29 | 31 | $2,914 | $1,554 | 53.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 147 | 176 | $46,565 | $13,206 | 28.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 72 | 72 | $24,353 | $8,545 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 148 | 168 | $36,836 | $7,930 | 21.5% |
About Dr. Gregory Dardas, MD
Dr. Gregory Dardas, MD is a Neurology healthcare provider based in Auburn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750350096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Dardas, MD has received a total of $5,972 in payments from pharmaceutical and medical device companies, with $335.59 received in 2024. These payments were reported across 400 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,936).
As a Medicare-enrolled provider, Dardas has provided services to 1,988 Medicare beneficiaries, totaling 2,434 services with total Medicare billing of $192,166. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Auburn, MI
- Active Since 03/17/2006
- Last Updated 09/12/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1750350096
Products in Payments
- TYSABRI (Biological) $1,021
- QULIPTA (Drug) $619.49
- ZEPOSIA (Drug) $442.42
- VUMERITY (Drug) $405.50
- KESIMPTA (Drug) $280.62
- Leqembi (Drug) $216.28
- Briviact (Drug) $191.55
- NURTEC ODT (Drug) $159.80
- EMGALITY (Drug) $136.94
- INGREZZA (Drug) $132.50
- OCREVUS (Biological) $131.30
- Aimovig (Biological) $130.81
- VALTOCO (Drug) $130.37
- TECFIDERA (Drug) $120.07
- UBRELVY (Drug) $111.57
- AJOVY (Biological) $98.34
- DUOPA (Drug) $92.99
- PLEGRIDY (Biological) $84.54
- TROKENDI XR (Drug) $80.77
- AVONEX (Biological) $72.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Auburn
Mitchell Ross, Md, MD
Neurology — Payments: $102,416
Neurology $102,416
Jianxin Ma, M.d, M.D
Neurology — Payments: $13,709
Neurology $13,709
Kanwardeep Grewal, M.d, M.D
Neurology — Payments: $7,099
Neurology $7,099
Ijaz Rashid, M.d, M.D
Neurology — Payments: $6,515
Neurology $6,515
Dr. Minna Hancock, D.o, D.O
Neurology — Payments: $5,064
Neurology $5,064
Dr. Paul Fu, M.d, M.D
Neurology — Payments: $4,489
Neurology $4,489